Sp740
PERSONALIZED ENDOSCOPY: ERGONOMICS AND THE ENDOSCOPE
Date
May 8, 2023
Explore related products in the following collection:
Society: AGA
This session will highlight the current state of the art around innovation in endoscopy as it pertains to climate, the environment, and the endoscopist. Our faculty experts will highlight the current state of disposable endoscopy, personalized endoscopy, ergonomics, climate change and GI health care.
This session will highlight the current state of the art around innovation in endoscopy as it pertains to climate, the environment, and the endoscopist. Our faculty experts will highlight the current state of disposable endoscopy, personalized endoscopy, ergonomics, climate change and GI health care.
Presenter
Tracks
Related Products
PLACEHOLDER
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
PLACEHOLDER
Perturbations in the gut mucosal immune response contributes to IBD. Non-immune cell popopulations including epithelial and stromal cells also play an important role in intestinal inflammation…
THE RIPPLE EFFECT: HOW COVID-19 HAS IMPACTED EQUITY AND OPPORTUNITY
The proposed session entitled, Equity and Opportunity in Creating your New Normal in the GI Workforce will have three key areas of focus 1) to explore equity and opportunity in the new era of work life integration; 2) to identify negotiating styles and skills to promote work/life balance in clinica…
MONITORING OF CALPROTECTIN IN INFLAMMATORY BOWEL DISEASE USING A SWEAT BASED WEARABLE DEVICE
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
